Linking To And Embedding Nick Norwitz’ “High Cholesterol and Plaque Regression?! Updates on KETO-CTA with Dave Feldman” With Links To Additional Resources

Posted on September 5, 2025 by Tom Wade MD

In addition to today’s resource, please see:

  • Carbohydrate Restriction-Induced Elevations in LDL-Cholesterol and Atherosclerosis: The KETO Trial. [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. JACC Adv. 2024 Aug 28;3(8):101109. doi: 10.1016/j.jacadv.2024.101109. eCollection 2024 Aug.
  • Longitudinal Data From the KETO-CTA Study: Plaque Predicts Plaque, ApoB Does Not. [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. JACC Adv. 2025 Jul;4(7):101686. doi: 10.1016/j.jacadv.2025.101686. Epub 2025 Apr 7.
  • The KETO CTA Study. [Full-Text HTML] [Full-Text PDF]. Letter JACC Adv. 2025 May 7;4(7):101861. doi: 10.1016/j.jacadv.2025.101861

Today, I review, link to, and embed Nick Norwitz‘ High Cholesterol and Plaque Regression?! Updates on KETO-CTA with Dave Feldman.

Sep 5, 2025 #keto #ketodiet #ketolifestyle

In this conversation with Dave Feldman, we explore updates on the controversial KETO-CTA study, and what it reveals about LDL cholesterol, ApoB, plaque progression, and heart disease risk, especially in lean mass hyper-responders on a ketogenic diet. We also discuss the debate and controversy surrounding the study, why we’ve had to remain quiet for so long, and the new results that have resulted from this study in the past few months. Whether you’ve been following the debate and drama, or if you’re interested in cholesterol science, ketogenic diets, cardiovascular imaging, or the debate over LDL and heart disease, this interview is a fun and educational watch.
Dave’s Presentation on Heart Flow vs Cleerly vs QAngio:    • New KETO-CTA Data – Clarification and Upda…  
Nick’s LDL 574 mg/dl article and video, Coming Soon at https://StayCuriousMetabolism.com

 

This entry was posted in Coronary Artery Disease, Coronary CT Angiogram, Coronary CT Angiography, Ketogenic Diet. Bookmark the permalink.